JP2009501333A5 - - Google Patents

Download PDF

Info

Publication number
JP2009501333A5
JP2009501333A5 JP2008520966A JP2008520966A JP2009501333A5 JP 2009501333 A5 JP2009501333 A5 JP 2009501333A5 JP 2008520966 A JP2008520966 A JP 2008520966A JP 2008520966 A JP2008520966 A JP 2008520966A JP 2009501333 A5 JP2009501333 A5 JP 2009501333A5
Authority
JP
Japan
Prior art keywords
gstp
stroke
level
subject
diagnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008520966A
Other languages
English (en)
Japanese (ja)
Other versions
JP5281397B2 (ja
JP2009501333A (ja
Filing date
Publication date
Priority claimed from GB0514435A external-priority patent/GB2428240A/en
Application filed filed Critical
Publication of JP2009501333A publication Critical patent/JP2009501333A/ja
Publication of JP2009501333A5 publication Critical patent/JP2009501333A5/ja
Application granted granted Critical
Publication of JP5281397B2 publication Critical patent/JP5281397B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008520966A 2005-07-14 2006-07-14 脳損傷関連障害の診断法 Active JP5281397B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0514435A GB2428240A (en) 2005-07-14 2005-07-14 Diagnostic method for brain damage-related disorders
GB0514435.7 2005-07-14
PCT/GB2006/050207 WO2007007129A2 (en) 2005-07-14 2006-07-14 Diagnostic method for brain damage-related disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013011339A Division JP2013092538A (ja) 2005-07-14 2013-01-24 脳損傷関連障害の診断法

Publications (3)

Publication Number Publication Date
JP2009501333A JP2009501333A (ja) 2009-01-15
JP2009501333A5 true JP2009501333A5 (enExample) 2009-06-18
JP5281397B2 JP5281397B2 (ja) 2013-09-04

Family

ID=34897198

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008520966A Active JP5281397B2 (ja) 2005-07-14 2006-07-14 脳損傷関連障害の診断法
JP2013011339A Pending JP2013092538A (ja) 2005-07-14 2013-01-24 脳損傷関連障害の診断法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013011339A Pending JP2013092538A (ja) 2005-07-14 2013-01-24 脳損傷関連障害の診断法

Country Status (10)

Country Link
US (1) US9028825B2 (enExample)
EP (1) EP1902319B1 (enExample)
JP (2) JP5281397B2 (enExample)
AT (1) ATE456055T1 (enExample)
AU (1) AU2006268034B2 (enExample)
CA (1) CA2613991C (enExample)
DE (1) DE602006011896D1 (enExample)
ES (1) ES2336946T3 (enExample)
GB (1) GB2428240A (enExample)
WO (1) WO2007007129A2 (enExample)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9929140D0 (en) * 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
AU2007247742B2 (en) 2006-05-09 2013-06-06 The University Of British Columbia Dissolved protein arthritis markers
DE102006048201A1 (de) * 2006-10-11 2008-04-17 Ganymed Pharmaceuticals Ag Autoantigene zur verbesserten Diagnose, Prognose und Therapie von entzündlichen neurologischen Erkrankungen
US20090104639A1 (en) * 2007-09-12 2009-04-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Biomarkers for motor neuron disease
KR20180102215A (ko) 2007-11-27 2018-09-14 더 유니버시티 오브 브리티쉬 콜롬비아 관절염의 진단과 치료를 위한 14-3-3 에타 항체 및 이의 용도
CA2878025C (en) 2008-01-18 2018-12-11 President And Fellows Of Harvard College Methods of detecting signatures of disease or conditions in bodily fluids
EP2277049A4 (en) * 2008-05-09 2012-05-30 Univ Duke AUTOANTIKÖRPER FOR THE PROOF AND THE TREATMENT OF CANCER
JP5781436B2 (ja) 2008-08-11 2015-09-24 バンヤン・バイオマーカーズ・インコーポレーテッド 神経学的状態のバイオマーカー検出方法およびアッセイ
DK2389587T3 (en) * 2009-01-26 2014-03-03 Electrophoretics Ltd Diagnostic and prognostic methods related Alzheimer's Disease
AU2009339152B2 (en) * 2009-01-30 2015-11-19 Bio-Rad Europe Gmbh Method for the in vitro diagnosis of stroke
CA2754741C (en) 2009-03-11 2019-02-12 Augurex Life Sciences Corporation Compositions and methods for characterizing arthritic conditions
CA2807645C (en) * 2009-08-07 2021-09-07 Affinimark Technologies, Inc. Device and methods for the immunological identification of cerebrospinal fluid
HUE040281T2 (hu) * 2009-09-14 2019-03-28 Banyan Biomarkers Inc Autoantitest markerek traumás agysérülés diagnózisára
RU2422095C1 (ru) * 2009-12-11 2011-06-27 Федеральное государственное учреждение "Ростовский научно-исследовательский онкологический институт Федерального агентства по высокотехнологичной медицинской помощи" Способ прогнозирования эффективности местной химиотерапии при лечении больных злокачественными опухолями головного мозга
WO2011106322A2 (en) * 2010-02-23 2011-09-01 The Govt. Of The U.S.A. As Represented By The Secretary, Department Of Health And Human Services. Biomarkers for acute ischemic stroke
GB201008541D0 (en) * 2010-05-21 2010-07-07 Univ Geneve Diagnostic methods
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
MX2013000917A (es) 2010-07-23 2013-07-05 Harvard College Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
EP2628013B1 (en) * 2010-10-14 2019-06-12 The Johns Hopkins University Biomarkers of brain injury
EP3279668B1 (en) * 2010-12-16 2019-05-15 National Institute of Advanced Industrial Science and Technology Method for enrichment and separation of spinal fluid glycoprotein, method for searching for marker for central nervous system diseases which utilizes the aforementioned method, and marker for central nervous system diseases
WO2012152970A1 (es) * 2011-05-06 2012-11-15 Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol Método de diagnóstico del ictus isquémico
EP2707389B1 (en) 2011-05-12 2019-10-30 The Johns Hopkins University Assay reagents for a neurogranin diagnostic kit
JP6096781B2 (ja) * 2011-09-22 2017-03-15 バイオ−ラッド ラボラトリーズ，インコーポレイティド 生化学データ分析システム及び方法
BR112014009536A2 (pt) 2011-10-21 2017-04-18 Augurex Life Sciences Corp antígenos derivados de 14-3-3 xitrulinada e usos dos mesmos no diagnóstico de artrite reumatoide
WO2013090285A1 (en) * 2011-12-14 2013-06-20 University Of Rochester Method of diagnosing mild traumatic brain injury
US9709573B2 (en) 2012-03-13 2017-07-18 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
WO2013163345A1 (en) * 2012-04-24 2013-10-31 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of stroke or other cerebral injury
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
JP2015522260A (ja) 2012-06-15 2015-08-06 ハリー スティリ， 疾患または状態を検出する方法
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
EP2965077B1 (en) 2013-03-09 2022-07-13 Harry Stylli Methods of detecting cancer
CN105659093A (zh) * 2013-06-28 2016-06-08 株式会社Mcbi 认知功能障碍疾病的生物标记物及使用该生物标记物的认知功能障碍疾病的检测方法
WO2015009907A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
EP4428251A3 (en) 2014-09-11 2024-12-18 Immunis.AI, Inc. Methods of detecting prostate cancer
FI20155280L (fi) * 2015-04-15 2016-10-16 Medicortex Finland Oy Aivovamman prognostisia ja diagnostisia glykaanipohjaisia biomarkkereita
CN105506083B (zh) * 2015-12-24 2018-10-19 孙梅芬 Capg在制备诊断帕金森症产品中的用途
JP6947451B2 (ja) * 2016-06-29 2021-10-13 学校法人自治医科大学 バイオマーカー、診断用組成物、及び診断用キット
WO2018002362A1 (en) * 2016-06-30 2018-01-04 Randox Laboratories Ltd Measurement of fabp for diagnosis
JPWO2018030252A1 (ja) * 2016-08-09 2019-06-20 大塚製薬株式会社 尿バイオマーカーを用いたアルツハイマー病の診断補助方法
US10914748B2 (en) 2016-09-08 2021-02-09 UNIVERSITé LAVAL Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease
EP3513196A1 (en) * 2016-09-16 2019-07-24 Dyax Corp. Protein biomarkers for diseases associated with the contact activation system
CN110366558A (zh) 2016-10-28 2019-10-22 班扬生物标记公司 针对泛素c末端水解酶l1(uch-l1)和胶质纤维酸性蛋白(gfap)的抗体及相关方法
KR102466369B1 (ko) * 2020-08-04 2022-11-14 서울대학교병원 자가면역 뇌염의 진단 방법
JP7569552B2 (ja) * 2021-01-29 2024-10-18 国立大学法人東北大学 認知症診断用のバイオマーカー
CN114966045A (zh) * 2022-05-07 2022-08-30 浙江大学 检测抗肌球蛋白轻链1-IgG自身抗体的试剂在制备检测血管内皮损伤的试剂盒中的应用
CN115166260B (zh) * 2022-07-11 2023-06-13 东南大学 血浆脑细胞来源外泌体中维生素d结合蛋白在诊断抑郁症中的应用
CN118624905B (zh) * 2023-07-31 2025-04-01 中国人民解放军总医院第一医学中心 一种糖尿病性肾病诊断的生物标志物和试剂盒及诊断设备
CN120820725A (zh) * 2025-09-17 2025-10-21 上海交通大学医学院附属仁济医院 胶质纤维酸性蛋白和乳酸脱氢酶a亚型在制备诊断颅脑创伤的试剂盒中的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017A (en) * 1845-05-01 Reid r
US3015A (en) * 1843-03-21 Improvement in gilding, silvering
GB225245A (en) * 1923-11-23 1924-12-24 British Thomson Houston Co Ltd Improvements in and relating to elastic fluid turbines
GB322063A (en) * 1928-10-29 1929-11-28 Godwin Stanley Oliver Improvements relating to automatic vehicle-controlled track-signalling devices
JPH09110713A (ja) * 1995-10-13 1997-04-28 Nippon Green Ueebu Kk グルタチオン−ｓ−トランスフェラーゼ活性化剤並びにそれを含む医薬品及び飲食物
CA2259122A1 (en) * 1996-06-17 1997-12-24 Max Planck Gesellschaft Zur Forderung Der Wissenschaften E.V. Novel ptp-20, pcp-2, bdp1, clk and sirp proteins and related products and methods
US6541615B1 (en) * 1996-11-15 2003-04-01 Max-Planck-Gellschaft Zur Foderung Der Wissenschaften E.V. SIRP proteins and uses thereof
CA2263063C (en) * 1999-02-26 2004-08-10 Skye Pharmatech Incorporated Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
AU1701001A (en) * 1999-11-30 2001-06-12 Eberhard-Karls-Universitat Tubingen Universitatsklinikum Antibodies against signal regulator proteins
GB9929140D0 (en) 1999-12-10 2000-02-02 Univ Geneve Diagnostic assay for stroke
GB2360089A (en) * 2000-03-10 2001-09-12 Univ Geneve Diagnostic assay for transmisible spongiform encephalopathies
EP1261875B1 (en) 2000-03-10 2007-08-01 Universite de Geneve Diagnostic assay for transmissible spongiform encephalopathies
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
AU2003274368B2 (en) * 2002-10-30 2008-11-20 Proteome Sciences Plc. Diagnostic method for transmissible spongiform encephalopathies (prion diseases)
EP1664795B1 (en) 2003-09-20 2017-11-08 Electrophoretics Limited Diagnostic method for brain damage-related disorders
EP1673465A4 (en) * 2003-09-29 2008-04-30 Biosite Inc PROCESS AND COMPOSITIONS FOR SEPSIS DIAGNOSIS
GB0419124D0 (en) 2004-08-27 2004-09-29 Proteome Sciences Plc Methods and compositions relating to Alzheimer's disease
GB0421639D0 (en) 2004-09-29 2004-10-27 Proteome Sciences Plc Methods and compositions relating to alzheimer's disease
WO2006061610A2 (en) 2004-12-07 2006-06-15 Electrophoretics Limited Diagnosis of neurodegenerative diseases

Similar Documents

Publication Publication Date Title
JP2009501333A5 (enExample)
JP6430413B2 (ja) アルツハイマー病の診断のための方法と組成物
JP5878875B2 (ja) アルツハイマー病の診断法
JP6415546B2 (ja) 脳卒中の鑑別診断を支援する方法
RU2014112348A (ru) Способ детекции нуклеосом, содержащих гистоновые варианты
RU2019106324A (ru) Гистоны и/или proadm в качестве маркеров, свидетельствующих о неблагоприятном событии
WO2009026432A1 (en) Improved alzheimer's diagnosis
CN104272112B (zh) 用于帮助诊断中风的基于生物标记的方法和生物芯片
JP2013504766A5 (enExample)
JP2018536170A5 (enExample)
Hu et al. Angiogenesis: a new surrogate histopathological marker is capable of differentiating between mild and significant portal hypertension
JP2012526543A5 (enExample)
JP2011523037A5 (enExample)
CN107589260A (zh) 尿液中mmp-7作为肾脏纤维化和慢性肾脏病的生物标志物的用途
JP2008504551A5 (enExample)
JP2007248395A5 (enExample)
WO2025054610A1 (en) Detection of dementia biomarkers using aptamer-modified graphene field-effect transistors
CA2571692A1 (en) Biomarkers of alzheimer's disease
WO2019169309A1 (en) Methods, apparatuses and kits for rapid testing of traumatic brain injuries
EP3639037A1 (en) Combinations for use in stroke diagnosis
WO2022271865A9 (en) Protein biomarker indicators of neurological injury and/or disease and methods of use thereof
KR101171716B1 (ko) 티오레독신 １을 유효성분으로 하는 난소암 또는 폐렴 진단용 조성물 및 이의 이용
EP3639036A1 (en) Improvements to stroke diagnosis
Masaebi et al. Assessing the Prediction Power of Plasma Neutrophil Gelatinase-Associated Lipocalin and Serum Cystatin C for Diagnosis Kidney Damage
JP2004251794A (ja) 痴呆症の検査方法